SpyGlass Pharma (SGP) director Dable Habib J files Form 3 showing no share ownership

Rhea-AI Filing Summary

SpyGlass Pharma, Inc. director Dable Habib J filed an initial ownership report stating no securities are beneficially owned. This Form 3 establishes that, as of the reported date, the director holds no direct or indirect ownership of SpyGlass Pharma stock or derivative securities.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dable Habib J

(Last) (First) (Middle)

C/O SPYGLASS PHARMA, INC.

27061 ALISO CREEK RD., SUITE 100

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/05/2026

3. Issuer Name and Ticker or Trading Symbol
SpyGlass Pharma, Inc. [ SGP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Brian Aukshunas, as Attorney-in-Fact	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the SpyGlass Pharma (SGP) Form 3 filing show for Dable Habib J?

The Form 3 shows that director Dable Habib J reports owning no SpyGlass Pharma securities. This includes both common stock and derivative securities, meaning there is no disclosed direct or indirect beneficial ownership as of the reported date.

Does Dable Habib J own any SpyGlass Pharma (SGP) shares according to this Form 3?

According to the Form 3, Dable Habib J beneficially owns no SpyGlass Pharma securities. Both the non-derivative and derivative tables show no holdings, and the remarks section confirms that no securities are beneficially owned by the reporting person.

What is the role of Dable Habib J at SpyGlass Pharma (SGP)?

Dable Habib J is identified as a director of SpyGlass Pharma. The Form 3 box for director is checked, while the officer, 10% owner, and other relationship boxes are not, indicating board membership without another listed executive role.

Why was this Form 3 filed for SpyGlass Pharma (SGP)?

The Form 3 is an initial statement of beneficial ownership for director Dable Habib J. It is required when someone becomes subject to Section 16 reporting, even if they currently hold no securities of SpyGlass Pharma at the time of the filing.

Are any derivative securities reported for Dable Habib J in SpyGlass Pharma (SGP)?

No derivative securities are reported for Dable Habib J. The table for derivative securities, such as options or warrants, contains no positions, and the remarks explicitly state that no securities are beneficially owned by the reporting person.

Who signed the SpyGlass Pharma (SGP) Form 3 for Dable Habib J?

The Form 3 is signed by Brian Aukshunas as attorney-in-fact for Dable Habib J. This indicates the filing was executed under a power of attorney, referenced as Exhibit 24 in the remarks section of the document.